Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
Recruiting now
Conditions studied: Thyroid Cancer
In brief
DTC has a generally favorable prognosis. The possibility to discriminate between patients with aggressive tumors and those with a more indolent behavior may reduce the need for unnecessary treatments. Aim of this observational study is to evaluate how anamnestic, clinical, and histopathological variables may influence the outcome of the enrolled patients, both regarding morbidity and mortality and in terms of therapeutic choices. The study aims to evaluate the prognostic impact of the therapeutic interventions in terms of efficacy and regarding the appearance of adverse events.
Key facts
- Study ID
- NCT05752604
- Run by
- Istituto Auxologico Italiano
- People needed
- 3000
- Starts
- 2022-07-12
- Expected to finish
- 2042-03-08
- Last updated by the study team
- 2025-08-03
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- thyroid cancer diagnosis
You may not qualify if…
- patients unable to sign informed consent
Where it is running
- Istituto Auxologico Italiano, IRCCS — Milan, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.